Ken Griffin Spdr Ser Tr Spdr S&P Biotech E Call Options Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2024

Call Options

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2024 May 15, 2024	SELL	$87.05 - $102.89 $15.1 Million - $17.8 Million	-173,200 Reduced 5.7%	2,868,000 $272 Million
Q4 2023 Feb 14, 2024	BUY	$64.12 - $90.86 $29.9 Million - $42.4 Million	466,700 Added 18.13%	3,041,200 $272 Million
Q3 2023 Nov 14, 2023	BUY	$71.88 - $85.76 $18.9 Million - $22.6 Million	263,400 Added 11.4%	2,574,500 $188 Million
Q2 2023 Aug 14, 2023	SELL	$75.38 - $90.23 $36.5 Million - $43.7 Million	-484,600 Reduced 17.33%	2,311,100 $192 Million
Q1 2023 May 15, 2023	SELL	$73.13 - $91.97 $12.6 Million - $15.8 Million	-171,900 Reduced 5.79%	2,795,700 $213 Million

Q4 2022 Feb 14, 2023	BUY	$77.2 - $85.66 $9.9 Million - $11 Million	128,200 Added 4.52%	2,967,600 $246 Million
Q3 2022 Nov 14, 2022	SELL	N/A	-622,700 Reduced 17.99%	2,839,400 $225 Million

Others Institutions Holding XBI

# of Institutions

920

Shares Held

99.8M

Call Options Held

24.7M

Put Options Held

43.4M

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.